-
2
-
-
0021153603
-
Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome
-
Austin III, H. A., L. R. Muenz, K. M. Joyce, et al. 1984. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 25: 689-695.
-
(1984)
Kidney Int.
, vol.25
, pp. 689-695
-
-
Austin, H.A.1
Muenz, L.R.2
Joyce, K.M.3
-
3
-
-
0026767866
-
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis
-
Boumpas, D. T., H. A. Austin III, E. M. Vaughn, et al. 1992. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet. 340: 741-745.
-
(1992)
Lancet
, vol.340
, pp. 741-745
-
-
Boumpas, D.T.1
Austin, H.A.2
Vaughn, E.M.3
-
4
-
-
0034687429
-
Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group
-
Chan, T. M., F. K. Li, C. S. Tang, et al. 2000. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N. Engl. J. Med. 343: 1156-1162.
-
(2000)
N. Engl. J. Med.
, vol.343
, pp. 1156-1162
-
-
Chan, T.M.1
Li, F.K.2
Tang, C.S.3
-
5
-
-
0035928643
-
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis
-
Illei, G. G., H. A. Austin, M. Crane, et al. 2001. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann. Intern. Med. 135: 248-257.
-
(2001)
Ann. Intern. Med.
, vol.135
, pp. 248-257
-
-
Illei, G.G.1
Austin, H.A.2
Crane, M.3
-
6
-
-
1442355581
-
Sequential therapies for proliferative lupus nephritis
-
Contreras, G., V. Pardo, B. Leclercq, et al. 2004. Sequential therapies for proliferative lupus nephritis. N. Engl. J. Med. 350: 971-980.
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 971-980
-
-
Contreras, G.1
Pardo, V.2
Leclercq, B.3
-
7
-
-
65649140169
-
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
-
Appel, G. B., G. Contreras, M. A. Dooley, et al. 2009. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J. Am. Soc. Nephrol. 20: 1103-1112.
-
(2009)
J. Am. Soc. Nephrol.
, vol.20
, pp. 1103-1112
-
-
Appel, G.B.1
Contreras, G.2
Dooley, M.A.3
-
8
-
-
20444466207
-
Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis
-
Chan, T. M., K. C. Tse, C. S. Tang, et al. 2005. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J. Am. Soc. Nephrol. 16: 1076-1084.
-
(2005)
J. Am. Soc. Nephrol.
, vol.16
, pp. 1076-1084
-
-
Chan, T.M.1
Tse, K.C.2
Tang, C.S.3
-
9
-
-
0033967634
-
Effects of mycophenolic acid on human renal proximal and distal tubular cells in vitro
-
Baer, P. C., S. Gauer, I. A. Hauser, et al. 2000. Effects of mycophenolic acid on human renal proximal and distal tubular cells in vitro. Nephrol. Dial. Transplant. 15: 184-190.
-
(2000)
Nephrol. Dial. Transplant.
, vol.15
, pp. 184-190
-
-
Baer, P.C.1
Gauer, S.2
Hauser, I.A.3
-
10
-
-
17044393532
-
Effects of mycophenolic acid on endothelial cells
-
Huang, Y., Z. Liu, H. Huang, et al. 2005. Effects of mycophenolic acid on endothelial cells. Int. Immunopharmacol. 5: 1029-1039.
-
(2005)
Int. Immunopharmacol.
, vol.5
, pp. 1029-1039
-
-
Huang, Y.1
Liu, Z.2
Huang, H.3
-
11
-
-
0036942639
-
Antiproliferative effect of mycophenolate mofetil on cultured human Tenon fibroblasts
-
Heinz, C., T. Hudde, K. Heise, and K. P. Steuhl. 2002. Antiproliferative effect of mycophenolate mofetil on cultured human Tenon fibroblasts. Graefes Arch. Clin. Exp. Ophthalmol. 240: 408-414.
-
(2002)
Graefes Arch. Clin. Exp. Ophthalmol.
, vol.240
, pp. 408-414
-
-
Heinz, C.1
Hudde, T.2
Heise, K.3
Steuhl, K.P.4
-
12
-
-
0032894546
-
Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion
-
Hauser, I. A., L. Renders, H. H. Radeke, et al. 1999. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol. Dial. Transplant. 14: 58-63.
-
(1999)
Nephrol. Dial. Transplant.
, vol.14
, pp. 58-63
-
-
Hauser, I.A.1
Renders, L.2
Radeke, H.H.3
-
13
-
-
67650065024
-
Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid
-
Yung, S., Q. Zhang, C. Z. Zhang, et al. 2009. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid. Arthritis Rheum. 60: 2071-2082.
-
(2009)
Arthritis Rheum.
, vol.60
, pp. 2071-2082
-
-
Yung, S.1
Zhang, Q.2
Zhang, C.Z.3
-
14
-
-
0036424451
-
Mycophenolic acid antagonizes the activation of cultured human mesangial cells
-
Dubus, I., B. Vendrely, I. Christophe, et al. 2002. Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int. 62: 857-867.
-
(2002)
Kidney Int.
, vol.62
, pp. 857-867
-
-
Dubus, I.1
Vendrely, B.2
Christophe, I.3
-
15
-
-
84930376257
-
Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-beta1 and collagen synthesis
-
Yung, S., C. Y. Ng, S. K. Ho, et al. 2015. Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-beta1 and collagen synthesis. J. Autoimmun. 58: 111-122.
-
(2015)
J. Autoimmun.
, vol.58
, pp. 111-122
-
-
Yung, S.1
Ng, C.Y.2
Ho, S.K.3
-
16
-
-
0033920978
-
Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney
-
Badid, C., M. Vincent, B. McGregor, et al. 2000. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int. 58: 51-61.
-
(2000)
Kidney Int.
, vol.58
, pp. 51-61
-
-
Badid, C.1
Vincent, M.2
McGregor, B.3
-
17
-
-
84864574499
-
Survival analysis and causes of mortality in patients with lupus nephritis
-
Yap, D. Y., C. S. Tang, M. K. Ma, et al. 2012. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol. Dial. Transplant. 27: 3248-3254.
-
(2012)
Nephrol. Dial. Transplant.
, vol.27
, pp. 3248-3254
-
-
Yap, D.Y.1
Tang, C.S.2
Ma, M.K.3
-
18
-
-
0036024147
-
Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupusprone MRL/lpr mice
-
Lui, S. L., R. Tsang, D. Wong, et al. 2002. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupusprone MRL/lpr mice. Lupus. 11: 411-418.
-
(2002)
Lupus
, vol.11
, pp. 411-418
-
-
Lui, S.L.1
Tsang, R.2
Wong, D.3
-
19
-
-
0016477799
-
Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice
-
Hahn, B. H., L. Knotts, M. Ng, and T. R. Hamilton. 1975. Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice. Arthritis Rheum. 18: 145-152.
-
(1975)
Arthritis Rheum.
, vol.18
, pp. 145-152
-
-
Hahn, B.H.1
Knotts, L.2
Ng, M.3
Hamilton, T.R.4
-
20
-
-
0028519835
-
Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide
-
Kiberd, B. A., and I. D. Young. 1994. Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide. J. Lab. Clin. Med. 124: 496-506.
-
(1994)
J. Lab. Clin. Med.
, vol.124
, pp. 496-506
-
-
Kiberd, B.A.1
Young, I.D.2
-
21
-
-
78649856319
-
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis
-
Moreth, K., R. Brodbeck, A. Babelova, et al. 2010. The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J. Clin. Invest. 120: 4251-4272.
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 4251-4272
-
-
Moreth, K.1
Brodbeck, R.2
Babelova, A.3
-
22
-
-
0038188642
-
Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy
-
Janssen, U., S. G. Riley, A. Vassiliadou, et al. 2003. Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int. 63: 2162-2170.
-
(2003)
Kidney Int.
, vol.63
, pp. 2162-2170
-
-
Janssen, U.1
Riley, S.G.2
Vassiliadou, A.3
-
23
-
-
84929307614
-
Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis
-
Xia, Y., L. C. Herlitz, S. Gindea, et al. 2015. Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis. J. Am. Soc. Nephrol. 26: 1053-1070.
-
(2015)
J. Am. Soc. Nephrol.
, vol.26
, pp. 1053-1070
-
-
Xia, Y.1
Herlitz, L.C.2
Gindea, S.3
-
24
-
-
78149305875
-
AntidsDNA antibodies bind to mesangial annexin II in lupus nephritis
-
Yung, S., K. F. Cheung, Q. Zhang, and T. M. Chan. 2010. AntidsDNA antibodies bind to mesangial annexin II in lupus nephritis. J. Am. Soc. Nephrol. 21: 1912-1927.
-
(2010)
J. Am. Soc. Nephrol.
, vol.21
, pp. 1912-1927
-
-
Yung, S.1
Cheung, K.F.2
Zhang, Q.3
Chan, T.M.4
-
25
-
-
33947215987
-
IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression
-
Herber, D., T. P. Brown, S. Liang, et al. 2007. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 178: 3822-3830.
-
(2007)
J. Immunol.
, vol.178
, pp. 3822-3830
-
-
Herber, D.1
Brown, T.P.2
Liang, S.3
-
26
-
-
0036232276
-
Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus
-
Chan, T. M., J. K. Leung, S. K. Ho, and S. Yung. 2002. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. J. Am. Soc. Nephrol. 13: 1219-1229.
-
(2002)
J. Am. Soc. Nephrol.
, vol.13
, pp. 1219-1229
-
-
Chan, T.M.1
Leung, J.K.2
Ho, S.K.3
Yung, S.4
-
27
-
-
33644661974
-
Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta
-
Yung, S., R. C. Tsang, J. K. Leung, and T. M. Chan. 2006. Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta. Kidney Int. 69: 272-280.
-
(2006)
Kidney Int.
, vol.69
, pp. 272-280
-
-
Yung, S.1
Tsang, R.C.2
Leung, J.K.3
Chan, T.M.4
-
28
-
-
0026568756
-
RS-61443 - A phase I clinical trial and pilot rescue study
-
Sollinger, H. W., M. H. Deierhoi, F. O. Belzer, et al. 1992. RS-61443 - a phase I clinical trial and pilot rescue study. Transplantation 53: 428-432.
-
(1992)
Transplantation
, vol.53
, pp. 428-432
-
-
Sollinger, H.W.1
Deierhoi, M.H.2
Belzer, F.O.3
-
29
-
-
0036226436
-
Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency
-
Haubitz, M., F. Bohnenstengel, R. Brunkhorst, et al. 2002. Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency. Kidney Int. 61: 1495-1501.
-
(2002)
Kidney Int.
, vol.61
, pp. 1495-1501
-
-
Haubitz, M.1
Bohnenstengel, F.2
Brunkhorst, R.3
-
30
-
-
0030975645
-
TGF-beta in kidney fibrosis: A target for gene therapy
-
Border, W. A., and N. A. Noble. 1997. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int. 51: 1388-1396.
-
(1997)
Kidney Int.
, vol.51
, pp. 1388-1396
-
-
Border, W.A.1
Noble, N.A.2
-
31
-
-
84862661539
-
Recent progress in the treatment of proliferative lupus nephritis
-
Chan, T. M. 2012. Recent progress in the treatment of proliferative lupus nephritis. Am. J. Med. 125: 642-648.
-
(2012)
Am. J. Med.
, vol.125
, pp. 642-648
-
-
Chan, T.M.1
-
32
-
-
77349120902
-
Influence of race/ethnicity on response to lupus nephritis treatment: The ALMS study
-
Isenberg, D., G. B. Appel, G. Contreras, et al. 2010. Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology 49: 128-140.
-
(2010)
Rheumatology
, vol.49
, pp. 128-140
-
-
Isenberg, D.1
Appel, G.B.2
Contreras, G.3
-
33
-
-
0035284737
-
Cutting edge: Reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide
-
Daikh, D. I., and D. Wofsy. 2001. Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J. Immunol. 166: 2913-2916.
-
(2001)
J. Immunol.
, vol.166
, pp. 2913-2916
-
-
Daikh, D.I.1
Wofsy, D.2
-
34
-
-
0037868032
-
Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition
-
Schiffer, L., J. Sinha, X. Wang, et al. 2003. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J. Immunol. 171: 489-497.
-
(2003)
J. Immunol.
, vol.171
, pp. 489-497
-
-
Schiffer, L.1
Sinha, J.2
Wang, X.3
-
35
-
-
0031927313
-
Attenuation of murine lupus nephritis by mycophenolate mofetil
-
Van Bruggen, M. C., B. Walgreen, T. P. Rijke, and J. H. Berden. 1998. Attenuation of murine lupus nephritis by mycophenolate mofetil. J. Am. Soc. Nephrol. 9: 1407-1415.
-
(1998)
J. Am. Soc. Nephrol.
, vol.9
, pp. 1407-1415
-
-
Van Bruggen, M.C.1
Walgreen, B.2
Rijke, T.P.3
Berden, J.H.4
-
36
-
-
0030944041
-
Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease
-
Corna, D., M. Morigi, D. Facchinetti, et al. 1997. Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Kidney Int. 51: 1583-1589.
-
(1997)
Kidney Int.
, vol.51
, pp. 1583-1589
-
-
Corna, D.1
Morigi, M.2
Facchinetti, D.3
-
37
-
-
28144433147
-
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
-
Ginzler, E. M., M. A. Dooley, C. Aranow, et al. 2005. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N. Engl. J. Med. 353: 2219-2228.
-
(2005)
N. Engl. J. Med.
, vol.353
, pp. 2219-2228
-
-
Ginzler, E.M.1
Dooley, M.A.2
Aranow, C.3
-
38
-
-
0030091604
-
Fibronectin is the major fibroblast chemoattractant in rabbit antiglomerular basement membrane disease
-
Gharaee-Kermani, M., R. Wiggins, F. Wolber, et al. 1996. Fibronectin is the major fibroblast chemoattractant in rabbit antiglomerular basement membrane disease. Am. J. Pathol. 148: 961-967.
-
(1996)
Am. J. Pathol.
, vol.148
, pp. 961-967
-
-
Gharaee-Kermani, M.1
Wiggins, R.2
Wolber, F.3
-
39
-
-
0030419494
-
Molecular insights into renal interstitial fibrosis
-
Eddy, A. A. 1996. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 7: 2495-2508.
-
(1996)
J. Am. Soc. Nephrol.
, vol.7
, pp. 2495-2508
-
-
Eddy, A.A.1
-
40
-
-
0026769228
-
Tubulointerstitial changes as a major determinant in the progression of renal damage
-
Nath, K. A. 1992. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am. J. Kidney Dis. 20: 1-17.
-
(1992)
Am. J. Kidney Dis.
, vol.20
, pp. 1-17
-
-
Nath, K.A.1
-
41
-
-
0031706340
-
The tubulointerstitium in progressive renal disease
-
Nath, K. A. 1998. The tubulointerstitium in progressive renal disease. Kidney Int. 54: 992-994.
-
(1998)
Kidney Int.
, vol.54
, pp. 992-994
-
-
Nath, K.A.1
-
42
-
-
84855280116
-
Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles
-
Bilyy, R. O., T. Shkandina, A. Tomin, et al. 2012. Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles. J. Biol. Chem. 287: 496-503.
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 496-503
-
-
Bilyy, R.O.1
Shkandina, T.2
Tomin, A.3
-
43
-
-
73949145491
-
C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells
-
Fraser, D. A., A. K. Laust, E. L. Nelson, and A. J. Tenner. 2009. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J. Immunol. 183: 6175-6185.
-
(2009)
J. Immunol.
, vol.183
, pp. 6175-6185
-
-
Fraser, D.A.1
Laust, A.K.2
Nelson, E.L.3
Tenner, A.J.4
-
44
-
-
72049083750
-
Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis
-
Menke, J., W. A. Rabacal, K. T. Byrne, et al. 2009. Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis. J. Am. Soc. Nephrol. 20: 2581-2592.
-
(2009)
J. Am. Soc. Nephrol.
, vol.20
, pp. 2581-2592
-
-
Menke, J.1
Rabacal, W.A.2
Byrne, K.T.3
-
45
-
-
79551654684
-
Distinct macrophage phenotypes contribute to kidney injury and repair
-
Lee, S., S. Huen, H. Nishio, et al. 2011. Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 22: 317-326.
-
(2011)
J. Am. Soc. Nephrol.
, vol.22
, pp. 317-326
-
-
Lee, S.1
Huen, S.2
Nishio, H.3
-
46
-
-
0027715980
-
Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing
-
Brown, L. F., D. Dubin, L. Lavigne, et al. 1993. Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am. J. Pathol. 142: 793-801.
-
(1993)
Am. J. Pathol.
, vol.142
, pp. 793-801
-
-
Brown, L.F.1
Dubin, D.2
Lavigne, L.3
-
47
-
-
0028866547
-
Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis
-
Barnes, J. L., E. S. Torres, R. J. Mitchell, and J. H. Peters. 1995. Expression of alternatively spliced fibronectin variants during remodeling in proliferative glomerulonephritis. Am. J. Pathol. 147: 1361-1371.
-
(1995)
Am. J. Pathol.
, vol.147
, pp. 1361-1371
-
-
Barnes, J.L.1
Torres, E.S.2
Mitchell, R.J.3
Peters, J.H.4
-
48
-
-
33644878084
-
Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: Implications on tubulointerstitial inflammation in lupus nephritis
-
Yung, S., R. C. Tsang, Y. Sun, et al. 2005. Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis. J. Am. Soc. Nephrol. 16: 3281-3294.
-
(2005)
J. Am. Soc. Nephrol.
, vol.16
, pp. 3281-3294
-
-
Yung, S.1
Tsang, R.C.2
Sun, Y.3
-
50
-
-
0027376265
-
Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus
-
Nagafuchi, H., N. Suzuki, Y. Mizushima, and T. Sakane. 1993. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J. Immunol. 151: 6525-6534.
-
(1993)
J. Immunol.
, vol.151
, pp. 6525-6534
-
-
Nagafuchi, H.1
Suzuki, N.2
Mizushima, Y.3
Sakane, T.4
-
51
-
-
0031112357
-
Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production
-
Takeno, M., H. Nagafuchi, S. Kaneko, et al. 1997. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J. Immunol. 158: 3529-3538.
-
(1997)
J. Immunol.
, vol.158
, pp. 3529-3538
-
-
Takeno, M.1
Nagafuchi, H.2
Kaneko, S.3
-
52
-
-
0028355713
-
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice
-
Ryffel, B., B. D. Car, H. Gunn, et al. 1994. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. Am. J. Pathol. 144: 927-937.
-
(1994)
Am. J. Pathol.
, vol.144
, pp. 927-937
-
-
Ryffel, B.1
Car, B.D.2
Gunn, H.3
-
53
-
-
0027930909
-
Interleukin 6 promotes murine lupus in NZB/NZW F1 mice
-
Finck, B. K., B. Chan, and D. Wofsy. 1994. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J. Clin. Invest. 94: 585-591.
-
(1994)
J. Clin. Invest.
, vol.94
, pp. 585-591
-
-
Finck, B.K.1
Chan, B.2
Wofsy, D.3
-
54
-
-
0142219897
-
The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: Critical determinants of disease susceptibility and progression?
-
Knight, D. A., M. Ernst, G. P. Anderson, et al. 2003. The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? Pharmacol. Ther. 99: 327-338.
-
(2003)
Pharmacol. Ther.
, vol.99
, pp. 327-338
-
-
Knight, D.A.1
Ernst, M.2
Anderson, G.P.3
-
55
-
-
33748067423
-
Mycophenolic acid inhibits mesangial cell activation through p38 MAPK inhibition
-
Ha, H., M. S. Kim, J. Park, et al. 2006. Mycophenolic acid inhibits mesangial cell activation through p38 MAPK inhibition. Life Sci. 79: 1561-1567.
-
(2006)
Life Sci.
, vol.79
, pp. 1561-1567
-
-
Ha, H.1
Kim, M.S.2
Park, J.3
-
56
-
-
10044232981
-
Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells
-
Park, J., H. Ha, J. Seo, et al. 2004. Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells. Am. J. Transplant. 4: 1982-1990.
-
(2004)
Am. J. Transplant.
, vol.4
, pp. 1982-1990
-
-
Park, J.1
Ha, H.2
Seo, J.3
-
57
-
-
77955983429
-
Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathway
-
Djamali, A., A. Vidyasagar, G. Yagci, et al. 2010. Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathway. Transplantation 90: 387-393.
-
(2010)
Transplantation
, vol.90
, pp. 387-393
-
-
Djamali, A.1
Vidyasagar, A.2
Yagci, G.3
|